These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25349592)

  • 1. Clinical application of genetics in management of colorectal cancer.
    Kim ER; Kim YH
    Intest Res; 2014 Jul; 12(3):184-93. PubMed ID: 25349592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer: epigenetic alterations and their clinical implications.
    Puccini A; Berger MD; Naseem M; Tokunaga R; Battaglin F; Cao S; Hanna DL; McSkane M; Soni S; Zhang W; Lenz HJ
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):439-448. PubMed ID: 28939182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
    Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.
    Legolvan MP; Taliano RJ; Resnick MB
    Hum Pathol; 2012 Aug; 43(8):1157-68. PubMed ID: 22658275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.
    Carethers JM; Jung BH
    Gastroenterology; 2015 Oct; 149(5):1177-1190.e3. PubMed ID: 26216840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.
    Nguyen HT; Duong HQ
    Oncol Lett; 2018 Jul; 16(1):9-18. PubMed ID: 29928381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
    Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
    Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways in colorectal cancer.
    Al-Sohaily S; Biankin A; Leong R; Kohonen-Corish M; Warusavitarne J
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1423-31. PubMed ID: 22694276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the genetics of sporadic colorectal cancer.
    Fischer J; Walker LC; Robinson BA; Frizelle FA; Church JM; Eglinton TW
    ANZ J Surg; 2019 Oct; 89(10):1224-1229. PubMed ID: 30919552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in colorectal cancer.
    Armaghany T; Wilson JD; Chu Q; Mills G
    Gastrointest Cancer Res; 2012 Jan; 5(1):19-27. PubMed ID: 22574233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular features of young-onset colorectal cancer.
    Ballester V; Rashtak S; Boardman L
    World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset colorectal cancer: a separate subset of colorectal cancer.
    Silla IO; Rueda D; Rodríguez Y; García JL; de la Cruz Vigo F; Perea J
    World J Gastroenterol; 2014 Dec; 20(46):17288-96. PubMed ID: 25516639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in colorectal cancer: Current clinical utility and future perspectives.
    Vacante M; Borzì AM; Basile F; Biondi A
    World J Clin Cases; 2018 Dec; 6(15):869-881. PubMed ID: 30568941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer carcinogenesis: a review of mechanisms.
    Tariq K; Ghias K
    Cancer Biol Med; 2016 Mar; 13(1):120-35. PubMed ID: 27144067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylator phenotype in colorectal cancer: A prognostic factor or not?
    Gallois C; Laurent-Puig P; Taieb J
    Crit Rev Oncol Hematol; 2016 Mar; 99():74-80. PubMed ID: 26702883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CpG island methylator phenotype (CIMP) in colorectal cancer.
    Nazemalhosseini Mojarad E; Kuppen PJ; Aghdaei HA; Zali MR
    Gastroenterol Hepatol Bed Bench; 2013; 6(3):120-8. PubMed ID: 24834258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis.
    Simons CC; Hughes LA; Smits KM; Khalid-de Bakker CA; de Bruïne AP; Carvalho B; Meijer GA; Schouten LJ; van den Brandt PA; Weijenberg MP; van Engeland M
    Ann Oncol; 2013 Aug; 24(8):2048-56. PubMed ID: 23532114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future biomarkers in the treatment of colorectal cancer.
    Cuyle PJ; Prenen H
    Acta Clin Belg; 2017 Apr; 72(2):103-115. PubMed ID: 27917697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal carcinogenesis--update and perspectives.
    Raskov H; Pommergaard HC; Burcharth J; Rosenberg J
    World J Gastroenterol; 2014 Dec; 20(48):18151-64. PubMed ID: 25561783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.